Changes in opioid prescribing and prescription drug monitoring program utilization following electronic health record integration-Massachusetts, 2018.

Autor:	Corry B; Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Cremer LJ; Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Donnelly C; Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Sargent WM Jr; Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA., Mells J; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA., Kelly R; Massachusetts Department of Public Health, Massachusetts Prescription Monitoring Program, Bureau of Health Professions Licensure, Boston, MA 02108, USA., Reynolds J; Massachusetts Department of Public Health, Massachusetts Prescription Monitoring Program, Bureau of Health Professions Licensure, Boston, MA 02108, USA., Young LD; Massachusetts Department of Public Health, Massachusetts Prescription Monitoring Program, Bureau of Health Professions Licensure, Boston, MA 02108, USA.
Jazyk:	angličtina
Zdroj:	Pain medicine (Malden, Mass.) [Pain Med] 2024 May 03; Vol. 25 (6), pp. 380-386.
DOI:	10.1093/pm/pnae012
Abstrakt:	Objective: In this study, we explored key prescription drug monitoring program-related outcomes among clinicians from a broad cohort of Massachusetts healthcare facilities following prescription drug monitoring program (PDMP) and electronic health record (EHR) data integration. Methods: Outcomes included seven-day rolling averages of opioids prescribed, morphine milligram equivalents (MMEs) prescribed, and PDMP queries. We employed a longitudinal study design to analyze PDMP data over a 15-month study period which allowed for six and a half months of pre- and post-integration observations surrounding a two-month integration period. We used longitudinal mixed effects models to examine the effect of EHR integration on each of the key outcomes. Results: Following EHR integration, PDMP queries increased both through the web-based portal and in total (0.037, [95% CI = 0.017, 0.057] and 0.056, [95% CI = 0.035, 0.077]). Both measures of clinician opioid prescribing declined throughout the study period; however, no significant effect following EHR integration was observed. These results were consistent when our analysis was applied to a subset consisting only of continuous PDMP users. Conclusions: Our results support EHR integration contributing to PDMP utilization by clinicians but do not support changes in opioid prescribing behavior. (Published by Oxford University Press on behalf of the American Academy of Pain Medicine.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu